Grace Hoben
About Grace Hoben
Grace Hoben is the Director at Bristol Myers Squibb in Redwood City, California, with over 13 years of experience in diagnostics, project management, and medical device instrumentation.
Company
Grace Hoben is currently employed at Bristol Myers Squibb as a Director. The company is located in Redwood City, California, United States. Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines for patients with serious diseases.
Title
Grace Hoben holds the position of Director at Bristol Myers Squibb. In this role, she oversees key initiatives and manages critical projects to advance the company's mission and strategic objectives.
Professional Experience
Grace Hoben has a diverse professional background with roles in various prestigious companies. She previously served as Associate Director, Portfolio Management- Tumor Microenvironment Modulation TRC, at Bristol Myers Squibb from 2020 to 2021. She worked at Johnson & Johnson Vision as Senior Project Manager from 2018 to 2020. Before that, she was the Senior Strategic Portfolio Manager at Roche Molecular Systems from 2015 to 2018 and the Global Project Manager from 2013 to 2015. Her tenure at Ventana Medical Systems, Inc included roles such as Project Manager, Companion Diagnostics, Scientist in R&D/Systems Integration Development, Senior R&D Research Associate, and Technical Product Manager-Antibodies between 2005 and 2013.
Education and Expertise
Grace Hoben studied at the University of Arizona from 2001 to 2005, earning a degree in Molecular Cellular Biology with a concentration in Physical Sciences. Her academic foundation has equipped her with extensive knowledge and expertise in Immunology, Oncology, Business Intelligence and Strategy, Project Management, Clinical Affairs, CMC, and Lean Manufacturing.
Industry Knowledge and Skills
Grace Hoben has over 13 years of progressive experience in the development, management, and launch of human disease diagnostic tests, companion diagnostics, and medical device instrumentation. She is affluent with medical device regulations such as 21CFR Parts 11, 50, 56, 312, 812, biopharmaceutical regulations, ICH, FDA, and GxP guidelines. She has a proven track record in leading teams, building collaborative relationships, and effectively communicating across functions, business units, and geographies.